Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kirshenbaum

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|June 10, 2020
Intentional Hydroxychloroquine Overdose Treated with High-Dose Diazepam: an Increasing Concern in the COVID-19 PandemicPeter R Chai, E G Ferro, J M Kirshenbaum, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|September 14, 2020
In Reply to "Hydroxychloroquine Overdose: What Are the Exact Roles of Diazepam and Potassium Infusion?"P R Chai, E G Ferro, J M Kirshenbaum, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 4, 2001
A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofibanD I Simon, C B Liu, P Ganz, et al.
The American Journal of Cardiology|November 1, 1985
Sequential balloon technique in angioplasty of severe coronary arterial obstructionsD C Levin, L M Boxt, R Abben, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1984
A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)-technetium(I) [Tc-99m TBI]: initial experience in the humanB L Holman, A G Jones, J Lister-James, et al.
European Journal of Nuclear Medicine|January 1, 1986
The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99m hexakis (t-butylisonitrile) technetium (I) (TBI): a new myocardial imaging agentS Campbell, B L Holman, J M Kirshenbaum, et al.
The American Journal of Cardiology|May 15, 1995
Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trialsC P Cannon, B Thompson, C H McCabe, et al.
The Journal of Clinical Investigation|January 1, 1988
Responses of coronary arteries of cardiac transplant patients to acetylcholineR D Fish, E G Nabel, A P Selwyn, et al.
The American Journal of Cardiology|December 15, 1991
Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study GroupJ M Kirshenbaum, R D Bahr, J T Flaherty, et al.
Circulation|April 1, 1989
Clot-selective coronary thrombolysis with pro-urokinaseJ Loscalzo, T P Wharton, J M Kirshenbaum, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|June 10, 2020
Intentional Hydroxychloroquine Overdose Treated with High-Dose Diazepam: an Increasing Concern in the COVID-19 PandemicPeter R Chai, E G Ferro, J M Kirshenbaum, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|September 14, 2020
In Reply to "Hydroxychloroquine Overdose: What Are the Exact Roles of Diazepam and Potassium Infusion?"P R Chai, E G Ferro, J M Kirshenbaum, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 4, 2001
A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofibanD I Simon, C B Liu, P Ganz, et al.
The American Journal of Cardiology|November 1, 1985
Sequential balloon technique in angioplasty of severe coronary arterial obstructionsD C Levin, L M Boxt, R Abben, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1984
A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)-technetium(I) [Tc-99m TBI]: initial experience in the humanB L Holman, A G Jones, J Lister-James, et al.
European Journal of Nuclear Medicine|January 1, 1986
The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99m hexakis (t-butylisonitrile) technetium (I) (TBI): a new myocardial imaging agentS Campbell, B L Holman, J M Kirshenbaum, et al.
The American Journal of Cardiology|May 15, 1995
Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trialsC P Cannon, B Thompson, C H McCabe, et al.
The Journal of Clinical Investigation|January 1, 1988
Responses of coronary arteries of cardiac transplant patients to acetylcholineR D Fish, E G Nabel, A P Selwyn, et al.
The American Journal of Cardiology|December 15, 1991
Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study GroupJ M Kirshenbaum, R D Bahr, J T Flaherty, et al.
Circulation|April 1, 1989
Clot-selective coronary thrombolysis with pro-urokinaseJ Loscalzo, T P Wharton, J M Kirshenbaum, et al.
Pageof 5